What to expect from drug targeting factor XI?

M. Nagy, H. ten Cate^*

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Pages (from-to)	E72-E74
Number of pages	3
Journal	Cardiovascular Research
Volume	118
Issue number	10
Early online date	22 Jun 2022
DOIs	https://doi.org/10.1093/cvr/cvac091
Publication status	Published - 27 Jul 2022

Keywords

Factor XI
Thrombosis
Anticoagulants
Prevention
Pleiotropy
PREVENTION

Access to Document

10.1093/cvr/cvac091Licence: CC BY

Cite this

@article{8905404db01049c5bb65e047f228f4f4,

title = "What to expect from drug targeting factor XI?",

keywords = "Factor XI, Thrombosis, Anticoagulants, Prevention, Pleiotropy, PREVENTION",

author = "M. Nagy and {ten Cate}, H.",

year = "2022",

month = jul,

day = "27",

doi = "10.1093/cvr/cvac091",

language = "English",

volume = "118",

pages = "E72--E74",

journal = "Cardiovascular Research",

issn = "0008-6363",

publisher = "Oxford University Press",

number = "10",

}

TY - JOUR

T1 - What to expect from drug targeting factor XI?

AU - Nagy, M.

AU - ten Cate, H.

PY - 2022/7/27

Y1 - 2022/7/27

KW - Factor XI

KW - Thrombosis

KW - Anticoagulants

KW - Prevention

KW - Pleiotropy

KW - PREVENTION

U2 - 10.1093/cvr/cvac091

DO - 10.1093/cvr/cvac091

M3 - Editorial

C2 - 35731157

SN - 0008-6363

VL - 118

SP - E72-E74

JO - Cardiovascular Research

JF - Cardiovascular Research

IS - 10

ER -